Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
Because another two wells have been successfully drilled? Or are you referring to the lower production numbers? Do we know how many days were lost to optimisation activities?
There's 100m barrels plus at Royston. Doesn't matter if you can't get it out.
Andy - the theory is that North are drip selling.
It will be more important for him to stick to his principles, and be seen to be sticking), than to deliver a workable solution for the country.
Yep, another top up for me as well.
Good price for the first purchase of the new ISA year.
And you can buy 4p cheaper than it was then. Amazing. Suspect a rush on Monday.
Yes, but there will be lots of 10% sellers as well, which will take time to churn through.
Keith - can we subtract the 8 days for mou5 from your calculation, as time to drill would be to TD, whereas the debate is about spud date? Either way, it's only a couple of months, and we have the highly anticipated Sandjet before that.
The $1m at 15 months is a minimum guaranteed payment. It does not preclude more or earlier.
Yes, the raise is going ahead in my view. Plan now is CIZ Bio will pay the US trial costs, which presumably includes any reagents required. However, AS mentioned three different tests in the plans requiring three different assays, so I'm not clear which is which, but I'm not going to worry about that - that's Prof Dawn's job. The point is there is a plan, licensing is happening, scaling up is progressing, trials are planned, revenue is forecast, progress is being made.
That's not what I heard. I heard that the plan was to spend some of that raise on trials, but now don't need to , saving $500k. AS stating that we are now well cashed up.
The second RNS explains the rather stilted / scripted interview. AS was being very guarded, knowing there was bigger news about to drop.
I'm currently watching the documentary series about Theranos. Given the similarities (at a very high level - a simple blood test that can provide a diagnosis via a machine without sending off to a lab) and the fact that we are aiming to launch in the US, I'm not surprised AS is playing it slow, steady and without fanfare. Theranos was an idea without the tech. To avoid being tarred with the same brush, we need to show the tech works conclusively before shouting about it, as I bet there is a fair bit of PTSD about and folks will be cautious and sceptical.
That 1.06 was my buy.
Strong move today. Not many sells. MM running out of shares?
Only if you are looking at a short term trade. Cash in the bank from placing, another $100k from this agreement. Guaranteed income in next 2 years. Steadily getting there. All for under £10m mcap.
Transfer of wealth to the patient?
I think folks looking for exact timelines for certification and commercialisation are going to be disappointed. It will happen when it happens. It might be two steps forward and one back as they optimise the solution but the main thing is progress is being made.
Sandjet. It's in the last presentation.